|
1
|
Jakóbisiak M and Lasek W: Immunologia
nowotworówImmunologia. Gołąb J, Jakóbisiak M, Lasek W and Stokłosa
T: 5th. Wydawnictwo Naukowe PWN; Warszawa: pp. 478–484. 2007
|
|
2
|
Kuss I, Hathaway B, Ferris RL, Gooding W
and Whiteside TL: Decreased absolute counts of T lymphocyte subsets
and their relation to disease in squamous cell carcinoma of the
head and neck. Clin Cancer Res. 10:3755–3762. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Edge SB, Byrd D, Compton CC, Fritz AG,
Greene F and Trotti A: American Joint Committee On CancerAJCC
Cancer Staging Manual. 7th. Springer; New York, NY: 2010
|
|
4
|
Kumar S, Skeen MJ, Adiri Y, Yoon H, Vezys
VD, Lukacher AE, Evavold BD, Ziegler HK and Boss JM: A cytokine
promoter/yellow fluorescent protein reporter transgene serves as an
early activation marker of lymphocyte subsets. Cell Immunol.
237:131–140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kwak Y, Koh J, Kim DW, Kang SB, Kim WH and
Lee HS: Immunoscore encompassing CD3+ and
CD8+ T cell densities in distant metastasis is a robust
prognostic marker for advanced colorectal cancer. Oncotarget.
7:81778–81790. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quatromoni JG, Wang Y, Vo DD, Morris LF,
Jazirehi AR, McBride W, Chatila T, Koya RC and Economou JS: T cell
receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to
transforming growth factor beta (TGFβ) signaling mediate superior
tumor regression in an animal model of adoptive cell therapy. J
Transl Med. 10:1272012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tauriello DV, Calon A, Lonardo E and
Batlle E: Determinants of metastatic competency in colorectal
cancer. Mol Oncol. 11:97–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ramnath N, Tan D, Li Q, Hylander BL,
Bogner P, Ryes L and Ferrone S: Is downregulation of MHC class I
antigen expression in human non-small cell lung cancer associated
with prolonged survival? Cancer Immunol Immunother. 55:891–899.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Salvi S, Fontana V, Boccardo S, Merlo DF,
Margallo E, Laurent S, Morabito A, Rijavec E, Dal Bello MG, Mora M,
et al: Evaluation of CTLA-4 expression and relevance as a novel
prognostic factor in patients with non-small cell lung cancer.
Cancer Immunol Immunother. 61:1463–1472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hamilton SR and Aaltonen LA: Tumours of
the colon and rectum In: World health organization classification
of tumoursPathology and genetics of tumours of the digestive
system. IARC Press; Lyon: pp. 103–104. 2000
|
|
12
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, Van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. European
organization for research and treatment of cancer, national cancer
institute of the united states, national cancer institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng
P, Xu P, Zhu D, Ji M and Xu J: Tumor deposit is a poor prognostic
indicator in patients who underwent simultaneous resection for
synchronous colorectal liver metastases. Onco Targets Ther.
8:233–240. 2015.PubMed/NCBI
|
|
14
|
Song YX, Gao P, Wang ZN, Liang JW, Sun Z,
Wang MX, Dong YX, Wang XF and Xu HM: Can the tumor deposits be
counted as metastatic lymph nodes in the UICC TNM staging system
for colorectal cancer? PLoS One. 7:e340872012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klintrup K, Mäkinen JM, Kauppila S, Väre
PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ and
Mäkinen MJ: Inflammation and prognosis in colorectal cancer. Eur J
Cancer. 41:2645–2654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salgado R, Denkert C, Demaria S, Sirtaine
N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL,
Penault-Llorca F, et al: The evaluation of tumor-infiltrating
lymphocytes (TILs) in breast cancer: Recommendations by an
international TILs working group 2014. Ann Oncol. 26:259–271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iseki Y, Shibutani M, Maeda K, Nagahara H,
Fukuoka T, Matsutani S, Kashiwagi S, Tanaka H, Hirakawa K and Ohira
M: A new method for evaluating tumor-infiltrating lymphocytes
(TILs) in colorectal cancer using hematoxylin and eosin
(H-E)-stained tumor sections. PLoS One. 13:e01927442018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Perez RO, Habr-Gama A, dos Santos RM,
Proscurshim I, Campos FG, Rawet V, Kiss D and Cecconello I:
Peritumoral inflammatory infiltrate is not a prognostic factor in
distal rectal cancer following neoadjuvant chemoradiation therapy.
J Gastrointest Surg. 11:1534–1540. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Liang L, Dai W, Cai G, Xu Y, Li X,
Li Q and Cai S: Prognostic impact of programed cell death-1 (PD-1)
and PD-ligand 1 (PD-L1) expression in cancer cells and tumor
infiltrating lymphocytes in colorectal cancer. Mol Cancer.
15:552016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Radzikowski C, Opolski A and Wietrzyk J:
Postęp w badaniach procesu wzrostu inwazyjnego i przerzutowania.
Nowotwory. 53:57–65. 2002.(In Polish).
|
|
21
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
LeBoit G, Burg G, Weedon D and Sarasin A:
Pathology and Genetics of Skin TumoursIARC Press; Lyon: 2005
|
|
23
|
Huh JW, Lee JH and Kim HR: Prognostic
significance of tumor-infiltrating lymphocytes for patients with
colorectal cancer. Arch Surg. 147:366–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pagès F, Galon J and Fridman WH: The
essential role of the in situ immune reaction in human colorectal
cancer. J Leukoc Biol. 84:981–987. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pagès F, Berger A, Camus M, Sanchez-Cabo
F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte
D, et al: Effector memory T cells, early metastasis, and survival
in colorectal cancer. N Engl J Med. 353:2654–2666. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mlecnik B, Tosolini M, Kirilovsky A,
Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman
WH, Pagès F and Galon J: Histopathologic-based prognostic factors
of colorectal cancers are associated with the state of the local
immune reaction. J Clin Oncol. 29:610–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buckowitz A, Knaebel HP, Benner A, Bläker
H, Gebert J, Kienle P, von Knebel Doeberitz M and Kloor M:
Microsatellite instability in colorectal cancer is associated with
local lymphocyte infiltration and low frequency of distant
metastases. Br J Cancer. 9:1746–1753. 2005. View Article : Google Scholar
|
|
28
|
Youssef MM, Paish EC, Murray JC, Farag NM,
Saleh K and Ellis IO: Tumor infiltrating T lymphocytes and
apoptosis in colorectal cancer. Egypt J Immunol. 22:19–28.
2015.PubMed/NCBI
|
|
29
|
Phillips SM, Banerjea A, Feakins R, Li SR,
Bustin SA and Dorudi S: Tumour-infiltrating lymphocytes in
colorectal cancer with microsatellite instability are activated and
cytotoxic. Br J Surg. 91:469–475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salama P, Phillips M, Grieu F, Morris M,
Zeps N, Joseph D, Platell C and Iacopetta BJ: Tumor-infiltrating
FOXP3+ T regulatory cells show strong prognostic
significance in colorectal cancer. Clin Oncol. 27:186–192. 2009.
View Article : Google Scholar
|
|
31
|
Ohtani H: Focus on TILs: Prognostic
significance of tumor infiltrating lymphocytes in human colorectal
cancer. Cancer Immun. 7:42007.PubMed/NCBI
|
|
32
|
Qi QH, Wang T, Mao Y and Hua D: Prognostic
significance of tumor deposits in patients with stage III colon
cancer. Zhonghua Zhong Liu Za Zhi. 38:784–789. 2016.(In Chinese).
PubMed/NCBI
|
|
33
|
Wei X, Qiu MZ, Zhou XY, He MM, Luo HY,
Wang FH, Zhang DS, Li YH and Xu RH: The clinicopathologic relevance
and prognostic value of tumor deposits and the applicability of N1c
category in rectal cancer with preoperative radiotherapy.
Oncotarget. 7:75094–75103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gopal P, Lu P, Ayers GD, Herline AJ and
Washington MK: Tumor deposits in rectal adenocarcinoma after
neoadjuvant chemoradiation are associated with poor prognosis. Mod
Pathol. 27:1281–1287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee WS, Kang M, Baek JH, Lee JI and Ha SY:
Clinical impact of tumor-infiltrating lymphocytes for survival in
curatively resected stage IV colon cancer with isolated liver or
lung metastasis. Ann Surg Oncol. 20:697–702. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schweiger T, Berghoff AS, Glogner C,
Glueck O, Rajky O, Traxler D, Birner P, Preusser M, Klepetko W and
Hoetzenecker K: Tumor-infiltrating lymphocyte subsets and tertiary
lymphoid structures in pulmonary metastases from colorectal cancer.
Clin Exp Metastasis. 33:727–739. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Halama N, Michel S, Kloor M, Zoernig I,
Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G,
Luber B, et al: Localization and density of immune cells in the
invasive margin of human colorectal cancer liver metastases are
prognostic for response to chemotherapy. Cancer Res. 71:5670–5677.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Morris M, Platell C and Iacopetta B:
Tumor-infiltrating lymphocytes and perforation in colon cancer
predict positive response to 5-fluorouracil chemotherapy. Clin
Cancer Res. 14:1413–1417. 2008. View Article : Google Scholar : PubMed/NCBI
|
